We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$383B
AUM Growth
+$14.2B
Cap. Flow
-$1.89B
Cap. Flow %
-0.5%
Top 10 Hldgs %
13.31%
Holding
4,419
New
190
Increased
1,733
Reduced
2,081
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$531M
2
KMI icon
Kinder Morgan
KMI
+$496M
3
IBM icon
IBM
IBM
+$253M
4
CA
CA, Inc.
CA
+$213M
5
EL icon
Estee Lauder
EL
+$209M

Sector Composition

Rank Sector Weight
1 Technology 16.01%
2 Financials 13.85%
3 Healthcare 13.68%
4 Industrials 10.26%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGLT
3951
DELISTED
Egalet Corporation
EGLT
$95K ﹤0.01%
16,600
-416
-2% -$2.42K
NTWK icon
3952
NetSol Technologies
NTWK
$48.7M
$94K ﹤0.01%
22,446
+43
+0.2% +$159
SVRA icon
3953
Savara
SVRA
$1.08B
$94K ﹤0.01%
2,390
FRTX
3954
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$94K ﹤0.01%
28
TEAR
3955
DELISTED
TearLab Corporation
TEAR
$94K ﹤0.01%
3,521
+10
+0.3% +$275
EMKR
3956
DELISTED
Emcore Corp
EMKR
$94K ﹤0.01%
1,775
+9
+0.5% +$476
FCX icon
3957
CALL
Freeport-McMoran
FCX
$93.5B
$93K ﹤0.01%
+3,986
New +$110K
PLBC icon
3958
Plumas Bancorp
PLBC
$443M
$93K ﹤0.01%
11,660
RLH
3959
DELISTED
Red Lions Hotel Corporation
RLH
$93K ﹤0.01%
14,739
ARQL
3960
DELISTED
Arqule Inc
ARQL
$93K ﹤0.01%
76,474
+475
+0.6% +$561
GNCA
3961
DELISTED
Genocea Biosciences, Inc.
GNCA
$93K ﹤0.01%
1,662
-35
-2% -$2.39K
IAG icon
3962
IAMGOLD
IAG
$10.2B
$92K ﹤0.01%
34,168
-44,070
-56% -$102K
JPS
3963
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$92K ﹤0.01%
+10,215
New +$91.9K
FCTY
3964
DELISTED
1st Century Bancshares
FCTY
$92K ﹤0.01%
14,500
CRNT icon
3965
Ceragon Networks
CRNT
$201M
$91K ﹤0.01%
89,977
-39,063
-30% -$56K
MBOT icon
3966
Microbot Medical
MBOT
$114M
$91K ﹤0.01%
60
TST
3967
DELISTED
TheStreet, Inc.
TST
$91K ﹤0.01%
3,833
+310
+9% +$6.99K
WSTL
3968
DELISTED
Westell Technologies Inc
WSTL
$91K ﹤0.01%
15,143
+97
+0.6% +$559
DHF
3969
BNY Mellon High Yield Strategies Fund
DHF
$176M
$90K ﹤0.01%
24,910
+1,910
+8% +$7.36K
IRD
3970
Opus Genetics
IRD
$310M
$90K ﹤0.01%
267
FBIO icon
3971
Fortress Biotech
FBIO
$99M
$89K ﹤0.01%
2,448
+3
+0.1% +$88
GRBK icon
3972
Green Brick Partners
GRBK
$3.02B
$89K ﹤0.01%
+10,858
New +$78.1K
STRR
3973
Star Equity Holdings
STRR
$37.5M
$88K ﹤0.01%
2,833
+2
+0.1% +$64
EDGW
3974
DELISTED
Edgewater Technology Inc
EDGW
$88K ﹤0.01%
11,789
CRWS icon
3975
Crown Crafts
CRWS
$28.7M
$87K ﹤0.01%
11,210
+4
+0% +$30

Similar funds

Bank of New York Mellon's Q4 2014 Portfolio in Review

As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
  • Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
  • Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
  • Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
  • Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
  • Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
  • Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.

Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.